Skip to content

Variant type and patient sex affect molnupiravir efficacy, study finds

  • by
  • blog
  • 1 min read

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study.

Advertisements
Advertisements
Advertisements

Join the conversation

Your email address will not be published. Required fields are marked *

Related Posts

In pictures: Mississippi tornado devastates town

Upside down houses and huge piles of debris are left in the wake of Friday’s deadly storm.

Mississippi tornado: Why was it so destructive?

The strength and timing of the tornado added to the devastation in Rolling Fork and elsewhere.

How to get metaverse payments right in 2023 and beyond

Customer trust will be key in the metaverse. Why orgs that build bulletproof platforms and protect user privacy will have most to gain.Read More